The U.S. government has made one of the most significant changes to marijuana policy in decades. In April 2026, the Drug Enforcement Administration (DEA), under direction from the U.S. Department of Justice, officially moved certain medical marijuana products from Schedule I to Schedule III under the Controlled Substances Act. For patients who rely on medical cannabis, this […]

Rescheduling marijuana. Will it be good or bad for medical marijuana? This article explores the benefits and the pitfalls should the DEA accept the recommendation from President Donald Trump to reschedule marijuana.

Marijuana is on track to be rescheduled from Schedule 1 to Schedule III on the Drug Enforcement Agency’s (DEA) controlled substances list. But what will that mean for medical marijuana patients in Louisiana? In this article, we’ll define the list and how rescheduling might affect marijuana patients and businesses in Louisiana. The History of Marijuana […]